Ilsung Is Co., Ltd.

Informe acción KOSE:A003120

Capitalización de mercado: ₩111.9b

Ilsung Is Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Seok-geun Yoon

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO46.1%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

Feb 20
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

Ilsung Pharmaceuticals (KRX:003120) Is Growing Earnings But Are They A Good Guide?

Jan 16
Ilsung Pharmaceuticals (KRX:003120) Is Growing Earnings But Are They A Good Guide?

Here's What Ilsung Pharmaceuticals Co., Ltd.'s (KRX:003120) Shareholder Ownership Structure Looks Like

Dec 18
Here's What Ilsung Pharmaceuticals Co., Ltd.'s (KRX:003120) Shareholder Ownership Structure Looks Like

Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

Nov 21
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years

CEO

Seok-geun Yoon (68 yo)

no data

Permanencia

Mr. Seok-geun Yoon is an insider at Ilsung Is Co., Ltd. (formerly known as Ilsung Pharmaceuticals Co., Ltd.) and serves as its Chairman and serves as its Chief Executive Officer and served as its Vice Chai...